XYNTHA
XYNTHA
Approved
DIN Number
02309483
Drug Class
Human
Market Date
Jan 23, 2009
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02309483
AIG Number0147521003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
MOROCTOCOG ALFAActive
Strength: 250 UNIT / VIAL
Monograph: MOROCTOCOG ALFA